Abstract
The biotechnology market in Asia-Pacific region looks very lucrative from
investment perspective as it has enjoyed double-digit growth in past few
years. The industry is attracting more and more private investments in wake of
immense growth opportunities and vast untapped biotech markets. Identifying
the future growth potential of the industry, the governments of different
countries in the Asia-Pacific region are taking up various initiatives to
promote research in the region. Overall, the Asia-Pacific biotech market is
expected to spur future growth in the global biotechnology market.
According to our new research report, “Asia Pacific Biotechnology Market
(2008-2012)”, the Asia-Pacific biotech market is projected to grow at a
CAGR of around 14% during 2010-2012. Currently, the industry is driven by new
developing markets like Malaysia and India where developments in the sector
are on a full swing. Anticipating the future growth, governments are promoting
the industry by making investments and implementing new strategies.
Our research has found that Japan and China are dominating the industry. While
higher growth rate has been witnessed in emerging markets like Malaysia, Japan
and China are anticipated to dominate the market in future with combined share
of around 70% of overall market. In this regard, our report provides rational
analysis of various factors which will drive this market over the forecast
period.
The report also provides extensive information and data of the biotech market
in the Asia-Pacific region as well as discusses the emerging trends like
contract research and manufacturing, bioinformatics, generics market etc. It
provides valuable information to pharmaceutical & biotechnology companies and
investors looking to enter these markets and help them to devise strategies in
accordance to the individual markets. The report also contains detailed
analysis and statistics of the market size, growth, share, segmentation,
geographic distribution and trends in technology development.
Table of Contents
1. Analyst View
2. Global Biotechnology Industry Overview
- 2.1 Market Overview
- 2.1.1 Product Segmentation
- 2.1.2 Geographical Segmentation
3. Asia-Pacific Biotechnology Market
- 3.1 Market Overview
- 3.1.1 Product Segmentation
- 3.1.2 Geographical Segmentation
- 3.1.3 Future Outlook (2010-2012)
- 3.2 Key Market Drivers
- 3.2.1 Strong Government Support
- 3.2.2 Strong and Low Cost Human Resources
- 3.2.3 Bio-diversity
4. Biotechnology Market by Country
- 4.1 Japan
- 4.1.1 Market Overview
- 4.1.2 Product Segmentation
- 4.1.3 Bio-clusters
- 4.1.4 Success and Risk Factors
- 4.1.5 Future Outlook (2010-2012)
- 4.2 China
- 4.2.1 Market Overview
- 4.2.2 Product Segmentation
- 4.2.3 Bio-clusters
- 4.2.4 Success and Risk Factors
- 4.2.5 Future Outlook (2010-2012)
- 4.3 India
- 4.3.1 Market Overview
- 4.3.2 Product Segmentation
- 4.3.3 Bio-clusters
- 4.3.4 Success and Risk Factors
- 4.3.5 Future Outlook (2010-11 to 2012-13)
- 4.4 Australia
- 4.4.1 Market Overview
- 4.4.2 Bio-clusters
- 4.4.3 Success and Risk Factors
- 4.4.4 Future Outlook (2010-2012)
- 4.5 Taiwan
- 4.5.1 Market Overview
- 4.5.2 Bio-clusters
- 4.5.3 Success and Risk Factors
- 4.5.4 Future Outlook (2010-2012)
- 4.6 South Korea
- 4.6.1 Market Overview
- 4.6.2 Product Segmentation
- 4.6.3 Bio-clusters
- 4.6.4 Success and Risk Factors
- 4.6.5 Future Outlook (2010-2012)
- 4.7 New Zealand
- 4.7.1 Market Overview
- 4.7.2 Product Segmentation
- 4.7.3 Success and Risk Factors
- 4.7.4 Future Outlook (2010-2012)
- 4.8 Singapore
- 4.8.1 Market Overview
- 4.8.2 Bio-clusters
- 4.8.3 Success and Risk Factors
- 4.8.4 Future Outlook (2010-2012)
- 4.9 Malaysia
- 4.9.1 Market Overview
- 4.9.2 Success and Risk Factors
- 4.9.3 Future Outlook (2010-2012)
5. Emerging Sectors
- 5.1 Contract Research and Manufacturing
- 5.2 Vaccines
- 5.3 Generics
- 5.4 Stem Cell Research
- 5.5 Nanotechnology
- 5.6 Bioinformatics
6. Roadblocks
- 6.1 IPR Regime
- 6.2 Private Participation
- 6.3 Lack of Bioventures
- 6.4 Inadequate Investment
7. Future Roadmap
- 7.1 Government Support
- 7.2 Role of Private Sector
- 7.3 Mergers & Acquisitions
- 7.4 Infrastructure Improvement
8. Competitive Landscape
- 8.1 Invitrogen Corporation
- 8.2 Takara Holdings, Inc.
- 8.3 CSL Limited
- 8.4 Biota Holdings Limited
- 8.5 GlaxoSmithKline Plc
List of Figures:
- Figure 2-1: Global - Biotechnology Market (Billion US$), 2007-2009
- Figure 2-2: Global - Forecast for Biotechnology Market (Billion US$),
2010-2012
- Figure 2-3: Global - Biotechnology Market by Segment (%), 2008
- Figure 2-4: Global - Biotechnology Market by Region (%), 2008
- Figure 3-1: Asia-Pacific - Biotechnology Market (Billion US$), 2008 & 2009
- Figure 3-2: Asia-Pacific - Biotechnology Market by Segment (%), 2008
- Figure 3-3: Asia-Pacific - Biotechnology Market by Country (%), 2008
- Figure 3-4: Asia-Pacific - Forecast for Biotechnology Market (Billion
US$), 2010-2012
- Figure 3-5: Asia-Pacific - Forecast for Biotechnology Market by Country
(%), 2012
- Figure 4-1: Japan - Biotechnology Market (Billion JPY), 2008 & 2009
- Figure 4-2: Japan - Biotechnology Market by Segment (%), 2007 & 2008
- Figure 4-3: Japan - Medical and Healthcare Biotechnology Market by Segment
(%), 2007
- Figure 4-4: Japan - Geographical Distribution of Bio-clusters
- Figure 4-5: Japan - Forecast for Biotechnology Market (Billion JPY),
2010-2012
- Figure 4-6: China - Biotechnology Market (Billion US$), 2008 & 2009
- Figure 4-7: China - Biotechnology Market by Segment (%), 2007
- Figure 4-8: China - Forecast for Biotechnology Market (Billion US$),
2010-2012
- Figure 4-9: India - Investment in Biotechnology Market (Million US$),
2006-07 to 2008-09
- Figure 4-10: India - Biotechnology Market (Billion INR), 2008-09 & 2009-10
- Figure 4-11: India - Export and Domestic Consumption of Biotechnology
Market (%), 2008-09
- Figure 4-12: India - Biotech Companies by Segment (%), 2006-07
- Figure 4-13: India - Biotechnology Market by Segment (%), 2008-09
- Figure 4-14: India - Biopharmaceutical Market by Segment (%), 2006-07
- Figure 4-15: India - Geographical Distribution of Bio-clusters
- Figure 4-16: India - Forecast for Biotechnology Market (Billion INR),
2010-11 to 2012-13
- Figure 4-17: India - Forecast for Biotechnology Market by Segment (%),
2012-13
- Figure 4-18: Australia - Biotechnology Market (Million US$), 2008 & 2009
- Figure 4-19: Australia - Biotech Companies by Sector (%), June 2008
- Figure 4-20: Australia - Geographical Distribution of Bio-clusters
- Figure 4-21: Australia - Forecast for Biotechnology Market (Million US$)
2010-2012
- Figure 4-22: Taiwan - Investment in Biotechnology Market (Million US$),
2006 & 2007
- Figure 4-23: Taiwan - Biotechnology Market (Billion US$), 2008 & 2009
- Figure 4-24: Taiwan - Forecast for Biotechnology Market (Billion US$),
2010-2012
- Figure 4-25: South Korea - Biotechnology Market (Billion US$), 2007-2009
- Figure 4-26: South Korea - Biotechnology Market by Segment (%)
- Figure 4-27: South Korea - Geographical Distribution of Bio-clusters
- Figure 4-28: South Korea - Forecast for Biotechnology Market (Billion
US$), 2010-2012
- Figure 4-29: New Zealand - Biotechnology Market (Million US$), 2008 & 2009
- Figure 4-30: New Zealand - Biotechnology Market by Segment (%)
- Figure 4-31: New Zealand - Biotech Companies by Sector (%), 2007
- Figure 4-32: New Zealand - Geographical Distribution of Bio-clusters (2005)
- Figure 4-33: New Zealand - Forecast for Biotechnology Market (Million
US$), 2010-2012
- Figure 4-34: Singapore - Biotechnology Market (Million US$), 2008 & 2009
- Figure 4-35: Singapore - Geographical Distribution of Bio-clusters
- Figure 4-36: Singapore - Forecast for Biotechnology Market (Million US$),
2010-2012
- Figure 4-37: Malaysia - Biotechnology Market (Million RM), 2008 & 2009
- Figure 4-38: Malaysia - Biotech Companies by Segment (%), 2008
- Figure 4-39: Malaysia - Forecast for Biotechnology Market (Million RM),
2010-2012
- Figure 5-1: India - Contract Research Market (Million US$), 2007, 2008 &
2010
- Figure 5-2: India - Contract Manufacturing Market (Million US$), 2007,
2008 & 2010
- Figure 5-3: Asia-Pacific - Generics Market (Billion US$), 2007-2009
- Figure 5-4: Global - Use of Nanoparticles in Biomedical Applications
(Million US$), 2007 & 2013
List of Tables:
- Table 3-1: Asia-Pacific - Top 10 Biotech Companies
- Table 4-1: Japan - Biotechnology Market by Segment (Billion JPY), 2007 &
2008
- Table 4-2: India - Top 20 Biotech Companies by Revenue (Billion INR),
2008-09
- Table 4-3: South Korea - Growth in Major Segments of Biotechnology Market
(%), 1999-2004
|
相關報告
|
